Chapter 322 |
2025 -- S 0692 SUBSTITUTE A Enacted 06/30/2025 |
A N A C T |
RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES |
Introduced By: Senator Melissa A. Murray |
Date Introduced: March 07, 2025 |
It is enacted by the General Assembly as follows: |
SECTION 1. Chapter 5-19.1 of the General Laws entitled "Pharmacies" is hereby amended |
by adding thereto the following section: |
5-19.1-37. Pharmacy technicians -- Scope of practice -- Pharmacy technician |
dispensing process validation within institutional pharmacies. |
(a) In accordance with chapter 19.1 of title 5 and adopted by the state board of pharmacy, |
a pharmacy technician or pharmacy intern may perform technology-assisted dispensing process |
validation for medications prepared for distribution by another pharmacy technician or intern |
within an institutional pharmacy. |
(b) Definitions. For purposes of this section, the following words and terms shall have the |
following meanings: |
(1) “Automated storage and distribution devices” means a mechanical device that delivers |
drugs other than by administration, and uses automated data processing technology to: |
(i) Provide effective storage and security of drugs contained in the device; |
(ii) Limit access to authorized individuals; |
(iii) Record the identity of all personnel who access the drugs stored within the device; |
(iv) Provide documentation of storage and removal of contents; |
(v) Provide ongoing documentation that monitors proper delivery of drugs to ensure patient |
safety; and |
(vi) Comply with all relevant statutes, rules, and regulations. |
(2) “Controlled substance" means a drug or substance, or an immediate precursor of such |
drug or substance, so designated under or pursuant to the provisions of chapter 28 of title 21. |
(3) “Dispensing process validation” means the physical verification that ensures the drug, |
drug dosage, and drug form selected is the correct drug, drug dosage, and drug form for the purpose |
for which it was selected. When applicable, dispensing process validation is subject to, and occurs |
after, licensed pharmacist drug utilization review and clinical conflict resolution. |
(4) “Institutional pharmacy” means any pharmacy that is located within or off-site, and |
contracted with, any hospital, clinic, or dispensary in which drugs are compounded or dispensed to |
its patients or patients of another licensed in-patient healthcare facility with whom it has a contract. |
(5) “Supervision” means oversight and control by a licensed pharmacist who is responsible |
for work performed by pharmacy technicians and pharmacy interns. |
(6) “Technology” means an electronic system designed to achieve accuracy in drug product |
identity verification including, but not limited to, barcode scanning and radio frequency |
identification (RFID). |
(c)(1) With regard to activities authorized, acting in compliance with this section, a licensed |
pharmacist may delegate, and a pharmacy technician or pharmacy intern may perform under the |
supervision of the pharmacist, technology-assisted dispensing process validation of medications |
prepared for distribution by another pharmacy technician or pharmacy intern when such medication |
will be administered to the patient by a licensed health care professional, including: |
(i) Patient-specific medication orders; |
(ii) Automated storage and distribution devices stock; |
(iii) Repackaged medication from bulk to unit-of-use doses; and |
(iv) Emergency kits. |
(2) Acting in compliance with this section, a licensed pharmacist shall not delegate |
dispensing process validation for: |
(i) Controlled substances; or |
(ii) Compounded products (whether sterile or non-sterile) unless the compounded products |
have been previously verified by a licensed pharmacist (e.g., previously batched compounded |
product). |
(3) In delegating activities under this section, a licensed pharmacist shall use reasonable |
professional judgment and shall ensure that authorized activities do not require the exercise of |
discretion or clinical judgment by the pharmacy technician or pharmacy intern. |
(d)(1) With regard to quality and control, the institutional pharmacy where activities |
authorized in this section are conducted shall: |
(i) Document a pharmacy technician or pharmacy intern dispensing process validation |
policy and procedure; |
(ii) Maintain an institutional pharmacy-specific training program including a record of |
pharmacy technicians and/or pharmacy interns trained; and |
(iii) Maintain a continuous quality assessment system to periodically verify the accuracy |
of the pharmacy technician or pharmacy intern dispensing process validation, including: |
(A) Recording any errors which reach the patient; |
(B) Recording any quality related events; and |
(C) Specific limits of acceptable quality related event levels before reassessment. |
(2) No pharmacy technician or pharmacy intern shall engage in authorized activities |
without documentation of training. |
(e) The pharmacist-in-charge is responsible for ensuring that delegation of technology- |
assisted dispensing process validation of medications by a licensed pharmacist under this section |
does not lead to medication errors. |
(f) With regards to rules and regulations, the board of pharmacy shall make, adopt, amend, |
and repeal such rules and regulations as may be deemed necessary by the board from time to time |
for the proper administration and enforcement of this section. Such rules and regulations shall be |
promulgated in accordance with the procedures specified in chapter 35 of title 42 ("administrative |
procedures"). |
SECTION 2. This act shall take effect upon passage. |
======== |
LC002231/SUB A |
======== |